|
DCLRE1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.722400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.357200E-01 |
| Normal-vs-Stage2 |
7.179600E-01 |
| Normal-vs-Stage3 |
1.777800E-01 |
| Normal-vs-Stage4 |
9.974000E-01 |
| Stage1-vs-Stage2 |
4.907400E-01 |
| Stage1-vs-Stage3 |
5.952200E-02 |
| Stage1-vs-Stage4 |
7.799000E-01 |
| Stage2-vs-Stage3 |
3.927400E-01 |
| Stage2-vs-Stage4 |
8.327600E-01 |
| Stage3-vs-Stage4 |
4.148000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.485000E-01 |
| Normal-vs-AfricanAmerican |
5.912800E-01 |
| Normal-vs-Asian |
7.093600E-01 |
| Caucasian-vs-AfricanAmerican |
3.948200E-01 |
| Caucasian-vs-Asian |
8.078800E-01 |
| AfricanAmerican-vs-Asian |
6.341800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.876000E-01 |
| Normal-vs-Female |
3.192300E-02 |
| Male-vs-Female |
2.136100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.320800E-01 |
| Normal-vs-Extreme_Weight |
3.840800E-01 |
| Normal-vs-Obese |
3.671200E-01 |
| Normal-vs-Extreme_Obese |
6.948000E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.008200E-01 |
| Normal_Weight-vs-Obese |
4.927000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.926000E-01 |
| Extreme_Weight-vs-Obese |
7.200100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.783800E-01 |
| Obese-vs-Extreme_Obese |
8.268100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.654400E-02 |
| Normal-vs-Age(41-60Yrs) |
4.261400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.240000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.414800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.250000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.255640E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.351900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.167600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.091180E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.539800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.347400E-01 |
| Normal-VS-Type2 PRCC |
9.615000E-01 |
| Normal-VS-KIRP CIMP |
9.413900E-02 |
| Normal-VS-Unclassified PRCC |
6.245800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.667800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.402900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.201900E-03 |
| Type2 PRCC-VS-KIRP CIMP |
5.305800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.435500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.307200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.391400E-01 |
| Normal-vs-N1 |
5.222100E-02 |
| Normal-vs-N2 |
5.033800E-01 |
| N0-vs-N1 |
1.020300E-02 |
| N0-vs-N2 |
3.905800E-01 |
| N1-vs-N2 |
9.574600E-01 |
|
|
